projectstartups.com

Ouro Medicines

Ouro Medicines is a biotechnology company developing immune reset therapeutics for chronic immune-mediated diseases. Their approach uses T cell engagers to target and deplete specific pathogenic cell populations, aiming to reset the immune system and create durable remissions without ongoing immunosuppression. Their lead product candidate, OM336, is a BCMA-directed bispecific T cell engager currently in a Phase 2 expansion study in China.


Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $120M

Date: 10-Jan-2025

Investors: TPG Life Sciences Innovations, NEA, Norwest Venture Partners, Monograph Capital, GSK, UPMC Enterprises, Boyu/Zoo Capital, LongRiver Investments

Markets: Biotechnology, Healthtech, Immunotherapy, Medical

HQ: San Francisco, California, United States

Founded: 2024

Website: https://www.ouromedicines.com/

LinkedIn: https://www.linkedin.com/company/ouromedicines

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/ouro-medicines

Pitchbook:

Download Funded Startups lists

Leave a Comment